EPIGRAL.BO(EPIGRAL.BO)
EPIGRAL.BO
No analyst ratings available
No analyst price targets available for EPIGRAL.BO
Analyst coverage may not be available for this symbol
No recent analyst actions
| Metric | FY2027E | FY2028E | FY2029E |
|---|---|---|---|
| Revenue Avg | $27.01B | $33.57B | $33.44B |
| Low | $24.34B | $32.53B | $31.38B |
| High | $29.67B | $34.61B | $35.50B |
| EBITDA Avg | $6.63B | $8.69B | $8.23B |
| Low | $6.02B | $8.46B | $7.92B |
| High | $7.25B | $8.93B | $8.54B |
| EBIT Avg | $4.28B | $5.56B | $4.48B |
| Low | $3.66B | $5.33B | $4.17B |
| High | $4.90B | $5.80B | $4.79B |
| Net Income Avg | $2.68B | $3.61B | $2.82B |
| Low | $2.23B | $3.44B | $2.60B |
| High | $3.13B | $3.78B | $3.05B |
| EPS Avg | $62.10 | $83.75 | $65.40 |
| Low | $51.70 | $79.77 | $60.16 |
| High | $72.50 | $87.73 | $70.64 |
| Analysts (Rev / EPS) | 2 / 2 | 2 / 2 | 1 / 1 |
| Metric | Q3 2026 |
|---|---|
| Revenue Avg | $6.84B |
| Low | $6.84B |
| High | $6.84B |
| EBITDA Avg | — |
| Low | — |
| High | — |
| EBIT Avg | — |
| Low | — |
| High | — |
| Net Income Avg | — |
| Low | — |
| High | — |
| EPS Avg | — |
| Low | — |
| High | — |
| Analysts (Rev / EPS) | 1 / — |